NASDAQ$ULBI

Ultralife Corporation · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Reported an operating loss due to supply chain challenges and acquisition costs.

Ultralife Corporation reported a decrease in revenue and operating income for Q4 2021 compared to the same period in 2020. The results were impacted by supply chain challenges, COVID-19 related logistics matters, and acquisition costs related to the Excell Battery Group. Despite these challenges, order flow remained strong and backlog increased.

  • Revenue decreased by 18.0% to $23.8 million compared to Q4 2020.
  • Operating loss was $1.2 million, compared to an operating income of $1.2 million in Q4 2020.
  • The company estimates that delayed shipments adversely impacted revenue by approximately $5.4 million and EPS by approximately $0.09.
  • Backlog at the end of the quarter increased to over $53 million, a 35% increase over year-end 2020 for the core business.

Headline financials

Total Revenue

$23.8M

Previous: $29M-18.0%
EPS (adj)

-$0.09

Previous: $0.17-152.9%
Capital Expenditures

$490K

Previous: $1.2M-59.1%
Free Cash Flow

-$4.63M

Previous: -$970K-377.0%
Net Income

-$1.1M

Previous: $2.1M-152.4%
Operating Income

-$1.2M

Previous: $1.2M-200.0%
Gross Profit

$5.3M

Previous: $7.4M-28.4%
Cash & Equivalents

$8.33M

Previous: $10.6M-21.1%
Total Assets

$160M

Previous: $138M+15.9%
Stock-Based Comp

$159K

Previous: $187K-15.0%

Revenue & EPS history

Ultralife · Revenue · Quarterly

$23.8M

Q4 2021-18%vs Q4 2020
Beat estimate in 5 of 7 quarters(71%)
ActualEstimate

Revenue by segment

Ultralife · $1.7M total across 1 segment · Q4 2021

  • Communications Systems
    $1.7M-54.1%

Forward guidance

The company's backlog, customer relationships, and new product initiatives support the view that long-term profitable growth drivers and strategy are sound and achievable.

Tailwinds

  • Strong order flow in medical and military end markets.
  • Backlog increased significantly, bolstered by Excell acquisition.
  • Continued advancement of transformational new product development projects.
  • Solid liquidity position after Excell acquisition and debt payoff.
  • Rebound in oil & gas revenues and performance of China operations.

Headwinds

  • Supply chain challenges associated with the global pandemic persisted.
  • Revenue and earnings were weighed down by supply chain issues.
  • Increased lead times on components from suppliers.
  • COVID-19 related logistics matters resulted in shipment delays.
  • Delayed shipments adversely impacted revenue and operating income.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+0.1%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+5.4%

Avg return

30 days after

46%

30 / 65 earnings

Positive

+56.6%

Q2 2023

Best reaction

-26.7%

Q2 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-14.3%-16.4%-4.6%
Q4 2025+8.3%+22.9%+28.5%
Q3 2025-9.0%-5.4%+4.7%
Q1 2025+2.9%+13.1%+57.8%
Q4 2024-6.1%-16.0%-18.2%
Q3 2024-14.3%-16.5%-18.3%
Q2 2024-3.1%-4.1%-1.8%
Q1 2024+30.5%+34.0%+29.4%
Q4 2023+16.5%+11.6%+6.6%
Q3 2023-22.3%-19.3%-18.2%
Q2 2023+56.6%+70.8%+87.4%
Q1 2023+3.6%-1.2%+4.9%
Q4 2022+0.5%-3.2%-0.2%
Q3 2022-4.6%-7.1%-15.4%
Q2 2022-4.1%-1.9%+8.8%
Q1 2022+6.4%+3.9%+7.1%
Q4 2021-7.4%-9.1%+0.9%
Q3 2021-9.3%-7.4%-19.9%
Q2 2021-6.3%-4.8%-5.3%
Q1 2021-1.4%-3.5%+14.0%
Q4 2020+8.2%+24.6%+11.9%
Q3 2020-9.8%-6.5%+20.1%
Q2 2020+1.7%+1.0%-9.7%
Q1 2020+7.6%+19.7%+19.3%
Q4 2019+11.4%+12.7%+0.0%
Q3 2019-7.1%-5.5%-6.4%
Q2 2019+6.0%-1.8%-1.8%
Q1 2019-18.1%-23.2%-30.0%
Q4 2018+4.1%+12.9%+26.1%
Q3 2018+10.9%+9.7%+8.4%
Q2 2018-3.5%-1.0%-13.5%
Q1 2018+3.3%+0.0%+12.1%
Q4 2017+7.6%+8.3%+19.7%
Q3 2017-14.3%-12.2%-12.9%
Q2 2017-2.2%-4.3%-6.5%
Q1 2017+7.2%+6.3%+20.7%
Q4 2016-1.0%+6.9%+8.8%
Q3 2016-7.8%-8.9%+6.7%
Q2 2016-7.6%-13.8%-11.0%
Q1 2016-11.0%
Q4 2015-4.5%
Q3 2015+5.3%
Q2 2015+0.0%
Q1 2015+1.5%
Q4 2014+9.7%
Q3 2014+5.7%
Q2 2014-8.3%
Q1 2014+7.2%
Q4 2013-5.2%
Q3 2013-4.5%
Q2 2013-0.3%
Q1 2013+1.8%
Q4 2012+11.2%
Q3 2012+5.9%
Q2 2012-26.7%
Q1 2011+0.5%
Q1 2012-1.0%
Q4 2011+0.6%
Q4 2009+0.6%
Q3 2011-3.0%
Q3 2010-3.0%
Q4 2010-0.2%
Q2 2010-0.2%
Q2 2011-0.2%
Q1 2010+4.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro